(Q42273410)

19 October 2017

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus (English)

1 reference

19 October 2017

1 reference

1 reference

1 reference

1 reference

1

1 reference

19 October 2017

2

Irina Isakova-Sivak

1 reference

19 October 2017

3

Svetlana Donina

1 reference

PubMed ID

23988294

19 October 2017

language of work or name

English

0 references

publication date

26 August 2013

1 reference

19 October 2017

1 reference

19 October 2017

31

1 reference

19 October 2017

42

1 reference

19 October 2017

4702-4705

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Global concerns regarding novel influenza A (H7N9) virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Immune epitope database analysis resource

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

From genome to vaccine—new immunoinformatics tools for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Improved method for predicting linear B-cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Phylogenetic analysis of the hemagglutinin gene of low pathogenic avian influenza virus H7N7 strains in mallards in Northern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.08.040

1 reference

19 October 2017

1 reference

PubMed ID

23988294